복약 컴플라이언스 모니터링 시장 : 제1판

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? There were 4.4 million connected medication compliance monitoring devices being used worldwide at the end of 2022. The market is forecasted to grow at a compound annual growth rate (CAGR) of 13.2 percent during the next years to reach an installed base of 8.2 million units by 2027. Medication compliance monitoring solutions include injected medication solutions, inhaled medication solutions as well as pill bottles and dispensers. Learn more about how wireless technology can become seamlessly integrated with these devices in this 120 - page in-depth report.

This report will allow you to:

• Profit from numerous executive interviews with market leading companies.

• Learn about key medication compliance monitoring devices and services.

• Study the strategies of 43 key players in the medication compliance monitoring ecosystem.

• Understand the market dynamics in North America, Europe and the Rest of World.

• Comprehend how technology can become seamlessly integrated with medical devices.

• Evaluate the business opportunities in the emerging medication adherence monitoring segment.

• Predict future market and technology developments.

Table of Contents

Table of Contents

List of Figures

Executive Summary

1. The Challenge of Chronic Diseases

• 1.1. Introduction
  • 1.1.1. The ageing population
• 1.2. Chronic diseases
  • 1.2.1. Cardiovascular diseases
  • 1.2.2. Chronic respiratory diseases
  • 1.2.3. Diabetes
• 1.3. Healthcare systems
  • 1.3.1. Healthcare in North America
  • 1.3.2. Healthcare in Europe
  • 1.3.3. Healthcare in Asia-Pacific
• 1.4. The regulatory environment
  • 1.4.1. Regulatory environment in North America
  • 1.4.2. Regulatory environment in Europe
  • 1.4.3. Regulatory environment in other major markets
  • 1.4.4. Medical data regulations
  • 1.4.5. Standardisation
• 1.5. The reimbursement environment

2. Medication Compliance Monitoring

• 2.1. Market overview
• 2.2. Form factors and use cases
  • 2.2.1. Injected medication solutions
  • 2.2.2. Inhaled medication solutions
  • 2.2.3. Pill bottle and dispenser solutions
• 2.3. Challenges with existing medication compliance technologies
• 2.4. Injected medication solution providers
  • 2.4.1. Beta Bionics
  • 2.4.2. Bigfoot Biomedical
  • 2.4.3. Biocorp
  • 2.4.4. Credence MedSystems
  • 2.4.5. Eli Lilly and Company
  • 2.4.6. Innovation Zed
  • 2.4.7. Insulet Corporation
  • 2.4.8. Medtronic
  • 2.4.9. Medtrum Technologies
  • 2.4.10. Merck Group
  • 2.4.11. Noble International (Aptar Group)
  • 2.4.12. Novo Nordisk
  • 2.4.13. Phillips-Medisize
  • 2.4.14. Roche
  • 2.4.15. Tandem Diabetes Care
  • 2.4.16. Ypsomed
• 2.5. Inhaled medication solution providers
  • 2.5.1. Adherium
  • 2.5.2. Amiko Digital Health
  • 2.5.3. Aptar Group
  • 2.5.4. Cognita Labs
  • 2.5.5. FindAir
  • 2.5.6. NuvoAir
  • 2.5.7. Propeller Health
  • 2.5.8. Teva Pharmaceutical Industries
• 2.6. Pill bottle and dispenser solution providers
  • 2.6.1. AARDEX Group
  • 2.6.2. AceAge
  • 2.6.3. AdhereTech
  • 2.6.4. Compliance Meds Technologies
  • 2.6.5. Evondos Group
  • 2.6.6. Hero Health
  • 2.6.7. Information Mediary Corporation
  • 2.6.8. iZafe Group
  • 2.6.9. Legrand Care
  • 2.6.10. Medimi
  • 2.6.11. MedMinder
  • 2.6.12. MedReady
  • 2.6.13. PharmAdva
  • 2.6.14. SMRxT
  • 2.6.15. Spencer Health Solutions
  • 2.6.16. Vaica
• 2.7. Medication compliance packaging solution providers
  • 2.7.1. Schreiner MediPharm
  • 2.7.2. WestRock
• 2.8. Digital Pills
  • 2.8.1. etectRx

3. Market Forecasts and Trends

• 3.1. Vendor landscape
• 3.2. Market analysis and forecasts
  • 3.2.1. Injected medication compliance monitoring solutions
  • 3.2.2. Inhaled medication compliance monitoring solutions
  • 3.2.3. Pill bottle and dispenser solutions
• 3.3. Market trends
  • 3.3.1. The market for connected medication management is gaining traction
  • 3.3.2. Launch of AI-based inhalers are revolutionizing the respiratory care market
  • 3.3.3. COVID-19 became a catalyst for the growth of mHealth solutions
  • 3.3.4. Healthcare staff shortages calls for efficient healthcare
  • 3.3.5. Advancing ingestible biosensor technology
  • 3.3.6. From remote patient monitoring to data-driven patient engagement
  • 3.3.7. Solution vendors show interest in sustainability
  • 3.3.8. Favourable policies that align financial incentives are driving RPM adoption
  • 3.3.9. A growing market and new entrants lead to a changing market landscape
  • 3.3.10. Shift in preference from traditional drug delivery to smart drug delivery
  • 3.3.11. BYOD has become a common option for telehealth
  • 3.3.12. M&As drive consolidation in the connected medication technology landscape
  • 3.3.13. Growing investment interest in the digital health market
  • 3.3.14. An ageing population increases healthcare expenditures
• List of Acronyms and Abbreviations